The present invention relates to specific binding members, particularly antibodies and fragments thereof, which bind to amplified epidermal growth factor receptor (EGFR) and to the de2-7 EGFR truncation of the EGFR. In particular, the epitope recognized by the specific binding members, particularly antibodies and fragments thereof, is enhanced or evident upon aberrant post-translational modification. These specific binding members are useful in the diagnosis and treatment of cancer. The binding members of the present invention may also be used in therapy in combination with chemotherapeutics or anti-cancer agents and/or with other antibodies or fragments thereof.
本发明涉及特定结合成员,尤其是与扩增的上皮生长因子受体(
EGFR)和
EGFR的de2-7
EGFR截短形式结合的
抗体及其片段。特别是,当发生异常的翻译后修饰时,特定结合成员,尤其是
抗体及其片段所识别的表位会被增强或显现。这些特定结合成员在癌症的诊断和治疗中非常有用。本发明的结合成员还可以与化疗药物或抗癌剂以及/或其他
抗体或其片段联合使用于治疗中。